News
33m
Asianet Newsable on MSNEli Lilly Inks Up To $1.3B Deal With Superluminal Medicines To Develop Obesity Drugs
Eli Lilly (LLY) has entered into a deal worth up to $1.3 billion with drug discovery company Superluminal Medicines to ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
Having backed Superluminal Medicines’ series A last year, Eli Lilly has now signed a $1.3 billion pact with the G ...
Mounjaro prices are to double on September 1 says the pharmaceutical giant that makes the weight loss jab. The 15mg pen is expected to cost ...
Eli Lilly will is set to raise the price of its weight loss and type two diabetes... VinFast's founder Pham Nhat Vuong has agreed to buy the EV maker's research and development... Coming into the ...
Eli Lilly has hiked the price of popular weight loss injections. The pharmaceutical giant, which manufactures the active ...
Eli Lilly ( NYSE: LLY) will raise the cost of its GLP-1/GIP receptor agonist Mounjaro (tirzepatide), approved for type 2 ...
Eli Lilly & Co. is raising the list price for its obesity shot in the UK, as the pharma industry comes under pressure from US ...
Eli Lilly will raise the list price in the UK of its weight-loss and type 2 diabetes treatment Mounjaro by 170% to be in line ...
The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK ...
Superluminal Medicines said on Thursday it had signed a deal with U.S. drugmaker Eli Lilly worth up to $1.3 billion to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results